KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accumulated Expenses (2016 - 2026)

Eli Lilly filings provide 18 years of Accumulated Expenses readings, the most recent being $1.4 billion for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 22.0% to $1.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 billion, a 22.0% increase, with the full-year FY2025 number at $2.4 billion, up 13.42% from a year prior.
  • Accumulated Expenses hit $1.4 billion in Q1 2026 for Eli Lilly, down from $2.4 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.4 billion in Q4 2025 to a low of $693.1 million in Q1 2022.
  • Median Accumulated Expenses over the past 5 years was $1.2 billion (2024), compared with a mean of $1.3 billion.
  • The widest YoY moves for Accumulated Expenses: up 55.73% in 2023, down 3.82% in 2023.
  • Eli Lilly's Accumulated Expenses stood at $1.1 billion in 2022, then skyrocketed by 55.73% to $1.7 billion in 2023, then rose by 26.88% to $2.1 billion in 2024, then increased by 13.42% to $2.4 billion in 2025, then crashed by 42.78% to $1.4 billion in 2026.
  • The last three reported values for Accumulated Expenses were $1.4 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.0 billion (Q3 2025) per Business Quant data.